Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Biobot Analytics, a US-based developer of technology to detect levels of the coronavirus in wastewater that is based on research at Massachusetts Institute of Technology, has obtained $20m in a funding round backed by The Engine, according to Bloomberg. Thursday Ventures led the round, with participation from insurance provider American Family Insurance’s impact investment arm Institute for Corporate and Social Impact, as well as Plum Alley Investments and private investors Anne Wojcicki and Tom Knight. Biobot is in discussions with one additional, unnamed investor to join the round. The money will allow Biobot to deploy its technology to test for Sars-Cov-2 and influenza by the end of the year, and also plans to restart efforts for its original focus on opioid. The Engine was among the investors in a $6.7m seed round closed in April 2020.

Hedron, a US-based satellite communications technology developer originally called Analytical Space, has raised…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).